1346602-84-3 Usage
Description
3-Vinylphenyl ethyl(methyl)-carbamate is an organic compound with a unique chemical structure that features a vinyl group attached to a phenyl ring, as well as an ethyl or methyl carbamate group. 3-Vinylphenyl ethyl(methyl)-carbamate is known for its potential applications in various industries due to its chemical properties.
Uses
Used in Pharmaceutical Industry:
3-Vinylphenyl ethyl(methyl)-carbamate is used as an intermediate in the synthesis of Rivastigmine (R541000), a cholinesterase inhibitor. Rivastigmine is a medication used to treat symptoms of mild to moderate dementia in patients with Alzheimer's disease and Parkinson's disease dementia. The compound plays a crucial role in the development of this therapeutic agent, contributing to its effectiveness in improving cognitive function and daily living skills.
Used in Chemical Synthesis:
3-Vinylphenyl ethyl(methyl)-carbamate can also be utilized as a building block in the synthesis of various other organic compounds. Its unique structure allows for further chemical reactions, making it a valuable component in the creation of new molecules with potential applications in different fields, such as materials science, agrochemicals, and more.
Check Digit Verification of cas no
The CAS Registry Mumber 1346602-84-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,6,0 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1346602-84:
(9*1)+(8*3)+(7*4)+(6*6)+(5*6)+(4*0)+(3*2)+(2*8)+(1*4)=153
153 % 10 = 3
So 1346602-84-3 is a valid CAS Registry Number.
1346602-84-3Relevant articles and documents
Synthesis of 3-vinylphenyl ethyl(methyl)carbamate: A potential human metabolite of rivastigmine
Xu, Guanhong,Ma, Teng,Yang, Jing,Wang, Fengliang,Zhang, Hongjuan,Wang, Xiuzhen,Li, Fei
, p. 3499 - 3500 (2013/04/24)
Convenient and efficient syntheses of 3-vinylphenyl ethyl (methyl) carbamate, one of potential metabolites from rivastigmine, has been developed. The overall yield is higher than 30% and represents the first direct synthesis of this metabolite from rivast
